(Radio)biological optimization of external-beam radiotherapy

Computational and Mathematical Methods in Medicine

Volumn 2012, Issue , 2012, Pages

  Nahum, Alan E ^a   Uzan, Julien ^a  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS;

EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL IMAGING; HYPOFRACTIONATED; INVERSE PLANNING; MODEL PARAMETERS; NORMAL TISSUE COMPLICATION PROBABILITIES; TISSUE ARCHITECTURE; TUMOUR CONTROL PROBABILITIES;

TUMORS;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER PROGRAM; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; PROCESS OPTIMIZATION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION PNEUMONIA; ALGORITHM; BIOLOGY; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; LUNG; LUNG TUMOR; METHODOLOGY; PATHOLOGY; RADIATION DOSE;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DOSE FRACTIONATION; HUMANS; LUNG; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SOFTWARE;

EID: 84870192609     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2012/329214     Document Type: Article

References (97)

1. Loverock L., Mayles P., Nahum A., Rosenwald J. C., Linear accelerators, ch. 36. Handbook of Radiotherapy Physics. Theory and Practice 2007 London, UK Taylor & Francis 197 239
2. Neal A., Mayles P., Nahum A., Rosenwald J. C., Patient data acquisition, ch. 30. Handbook of Radiotherapy Physics. Theory and Practice 2007 London, UK Taylor & Francis 647 655
3. Bidmead M., Rosenwald J. C., Mayles P., Nahum A., Rosenwald J. C., Dose evaluation of treatment plans, ch. 35. Handbook of Radiotherapy Physics. Theory and Practice 2007 London, UK Taylor & Francis 719 729
4. Mayle P., Williams P., Mayles P., Nahum A., Rosenwald J. C., Megavoltage photon beams, ch. 22. Handbook of Radiotherapy Physics. Theory and Practice 2007 London, UK Taylor & Francis 451 481
5. Tait D. M., Nahum A. E., Meyer L. C., Law M., Dearnaley D. P., Horwich A., Mayles W. P., Yarnold J. R., Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiotherapy and Oncology 1997 42 2 121 136 2-s2.0-0030970072 10.1016/S0167-8140(96)01870-1 (Pubitemid 27132741)
6. Lax I., Brahme A., Rotation therapy using a novel high-gradient filter. Radiology 1982 145 2 473 478 2-s2.0-0019915820 (Pubitemid 12002904)
7. Brahme A., Roos J. E., Lax I., Solution of an integral equation encountered in rotation therapy. Physics in Medicine and Biology 1982 27 10 1221 1229 2-s2.0-0019970864 (Pubitemid 12034105)
8. Webb S., Mayles P., Nahum A., Rosenwald J. C., Conformal and intensity-modulated radiotherapy. Handbook of Radiotherapy. Physics Theory and Practice 2007 London, UK Taylor & Francis 943 985
9. Iori M., Paiusco M., Cagni E., Riccardi S., Lambertini D., Bizzocchi N., Borasi G., Iotti C., D'Abbiero N., Nahum A. E., The intensity modulated multiple arc (imma) technique: forward & inverse planned procedures to deliver hypofractionated imat treatments. Current Radiopharmaceuticals 2009 2 3 149 159 2-s2.0-73649085624 10.2174/1874471010902030149
10. Mubata C., Mayles P., Nahum A., Rosenwald J. C., Portal imaging devices, ch. 14. Handbook Of Radiotherapy Physics. Theory And Practice 2007 London, UK Taylor & Francis 261 269
11. Jaffray D. A., Siewerdsen J. H., Wong J. W., Martinez A. A., Flat-panel cone-beam computed tomography for image-guided radiation therapy. International Journal of Radiation, Oncology, Biology, Physics 2002 53 5 1337 1349 2-s2.0-0036680147 10.1016/S0360-3016(02)02884-5 (Pubitemid 34787872)
12. Lomax A. J., Böhringer T., Bolsi A., Coray D., Emert F., Goitein G., Jermann M., Lin S., Pedroni E., Rutz H., Stadelmann O., Timmermann B., Verwey J., Weber D. C., Treatment planning and verification of proton therapy using spot scanning: initial experiences. Medical Physics 2004 31 11 3150 3157 2-s2.0-9244236564 10.1118/1.1779371 (Pubitemid 39552703)
13. Nyström H., The role of protons in modern and biologically-guided radiotherapy. Acta Oncologica 2010 49 7 1124 1131 2-s2.0-77956592675 10.3109/0284186X.2010.498436
14. Schippers J. M., Lomax A. J., Emerging technologies in proton therapy. Acta Oncologica 2011 50 6 838 850 2-s2.0-79960539223 10.3109/0284186X.2011. 582513
15. Roelofs E., Engelsman M., Rasch C., Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. Journal of Thoracic Oncology 2012 7 165 176
16. Viani G. A., Stefano E. J., Afonso S. L., Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. International Journal of Radiation, Oncology, Biology, Physics 2009 74 5 1405 1418 2-s2.0-67651112123 10.1016/j.ijrobp.2008. 10.091
17. Hoffmann A. L., Troost E. G. C., Huizenka H., Kaanders J. H. A. M., Bussink J., Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial. International Journal of Radiation Oncology, Biology, Physics 2012 83 1596 1602
18. Nahum A., Kutcher G., Mayles P., Nahum A., Rosenwald J. C., Biological evaluation of treatment plans, ch. 36. Handbook of Radiotherapy Physics Theory and Practice 2007 London, UK Taylor & Francis 731 771
19. Jackson A., Marks L. B., Bentzen S. M., Eisbruch A., Yorke E. D., Ten Haken R. K., Constine L. S., Deasy J. O., The Lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. International Journal of Radiation Oncology, Biology, Physics 2010 76 3 S155 S160 2-s2.0-76449087147 10.1016/j.ijrobp.2009.08.074
20. West C. M. L., Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. British Journal of Radiology 1995 68 812 827 837 2-s2.0-0029077215
21. Webb S., Nahum A. E., A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Physics in Medicine and Biology 1993 38 6 653 666 2-s2.0-0027223126 10.1088/0031-9155/38/6/001 (Pubitemid 23188329)
22. Nahum A. E., Sanchez-Nieto B., Tumour control probability modelling: basic principles and applications in treatment planning. Physica Medica 2001 17 2 13 23 2-s2.0-0034851923
23. Lyman J. T., Complication probability as assessed from dose-volume histograms. Radiation Research 1985 104 2 S13 S19 2-s2.0-0022323855 (Pubitemid 16149302)
24. Kutcher G. J., Burman C., Brewster L., Goitein M., Mohan R., Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. International Journal of Radiation Oncology, Biology, Physics 1991 21 1 137 146 2-s2.0-0026093854
25. Niemierko A., Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Medical Physics 1997 24 1 103 110 2-s2.0-0031037018 10.1118/1.598063 (Pubitemid 27051935)
26. Ebert M. A., Viability of the EUD and TCP concepts as reliable dose indicators. Physics in Medicine and Biology 2000 45 2 441 457 2-s2.0-0033965789 10.1088/0031-9155/45/2/313 (Pubitemid 30096774)
27. Niemierko A., A generalized concept of equivalent uniform dose (EUD). Medical Physics 1999 26 1101
28. Kwa S. L. S., Lebesque J. V., Theuws J. C. M., Marks L. B., Munley M. T., Bentel G., Oetzel D., Spahn U., Graham M. V., Drzymala R. E., Purdy J. A., Lichter A. S., Martel M. K., Ten Haken R. K., Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. International Journal of Radiation Oncology, Biology, Physics 1998 42 1 1 9 2-s2.0-0031688620 (Pubitemid 28435589)
29. Källman P., Agren A., Brahme A., Tumour and normal tissue responses to fractionated non-uniform dose delivery. International Journal of Radiation Biology 1992 62 2 249 262 2-s2.0-0026656051
30. Lawrence T. S., Tesser R. J., Ten Haken R. K., An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. International Journal of Radiation Oncology, Biology, Physics 1990 19 4 1041 1047 2-s2.0-0024990548 (Pubitemid 20345178)
31. Nahum A. E., Tait D. M., Breit A., Maximising local control by customised dose prescription for pelvic tumours. Advanced Radiation Therapy: Tumour Response Monitoring and Treatment Planning 1992 Heidelberg, Germany Springer 425 431
32. Sanchez-Nieto B., Nahum A. E., Dearnaley D. P., Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. International Journal of Radiation Oncology, Biology, Physics 2001 49 2 487 499 2-s2.0-0035253829 10.1016/S0360-3016(00)01508-X (Pubitemid 32120247)
33. Van Baardwijk A., Wanders S., Boersma L., Borger J., Öllers M., Dingemans A. M. C., Bootsma G., Geraedts W., Pitz C., Lunde R., Lambin P., De Ruysscher D., Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. Journal of Clinical Oncology 2010 28 8 1380 1386 2-s2.0-77950466471 10.1200/JCO.2009.24.7221
34. Fenwick J. D., Nahum A. E., Malik Z. I., Eswar C. V., Hatton M. Q., Laurence V. M., Lester J. F., Landau D. B., Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clinical Oncology 2009 21 4 343 360 2-s2.0-62749193775 10.1016/j.clon.2008.12.011
35. De Jaeger K., Hoogeman M. S., Engelsman M., Seppenwoolde Y., Damen E. M. F., Mijnheer B. J., Boersma L. J., Lebesque J. V., Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. Radiotherapy and Oncology 2003 69 1 1 10 2-s2.0-0242321252 10.1016/S0167-8140(03)00195-6 (Pubitemid 37346183)
36. Malik Z., Eswar C., Clinical audit of NSCLC radiotherapy outcomes at Clatterbridge Centre for Oncology. unpublished
37. Nahum A. E., Uzan J., Jain P., Malik Z. I., Fenwick J. D., Baker C., Quantitative tumour control predictions for the radiotherapy of non-small-cell lung tumours. Medical Physics 2011 38 1, article 3641
38. Malik Z., Eswar C., Dobson J., Fenwick J., Nahum A. E., Dose-individualisation for lung cancer radiotherapy-are we ready? Lung Cancer 2007 57 1, supplement S8 S9
39. Martel M. K., Ten Haken R. K., Hazuka M. B., Kessler M. L., Strawderman M., Turrisi A. T., Lawrence T. S., Fraass B. A., Lichter A. S., Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999 24 1 31 37 2-s2.0-0033045661 10.1016/S0169-5002(99)00019-7 (Pubitemid 29241815)
40. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., Parmar M., Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiotherapy and Oncology 1999 52 2 137 148 2-s2.0-0033179899 10.1016/S0167-8140(99)00087-0 (Pubitemid 29461081)
41. Withers H. R., Thames H. D., Peters L. J., A new isoeffect curve for change in dose per fraction. Radiotherapy and Oncology 1983 1 2 187 191 2-s2.0-0021018966 (Pubitemid 14182317)
42. Calandrino R., Broggi S., Cattaneo G. M., Fiorino C., Nahum A. E., Fazio F., Some radiobiological considerations on the potential of IMRT in non-standard fractionation. Radiotherapy & Oncology 2005 76 S23
43. Panettieri V., Malik Z. I., Eswar C. V., Landau D. B., Thornton J. M. C., Nahum A. E., Mayles W. P. M., Fenwick J. D., Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy. Radiotherapy and Oncology 2010 97 3 418 424 2-s2.0-78651502968 10.1016/j.radonc.2010.06.015
44. Lester J., Nixon L., Mayles P., The I-START Trial: ISoToxic accelerated radio therapy in locally advanced non-small cell lung cancer, 2012 The I-START Trial: ISoToxic accelerated radioTherapy in locally advanced non-small cell lung cancer. Lung Cancer 2012 75 1, supplement S51
45. Thames H. D., Hendry J. H., Fractionation in Radiotherapy 1987 London, UK Taylor & Francis
46. Steel G., Mayles P., Nahum A., Rosenwald J. C., Dose fractionation in radiotherapy, ch. 9. Handbook of Radiotherapy Physics Theory and Practice 2007 London, UK Taylor & Francis 163 182
47. Joiner M. C., Bentzen S. M., Joiner M., van der Kogel A., Fractionation: the linear quadratic approach. Basic Clinical Radiobiology 2009 4th Hodder Arnold 102 119
48. Dale R. G., The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. British Journal of Radiology 1985 58 690 515 528 2-s2.0-0021812109 (Pubitemid 15018411)
49. Fowler J. F., 21 Years of biologically effective dose. British Journal of Radiology 2010 83 991 554 568 2-s2.0-77954465652 10.1259/bjr/31372149
50. Bentzen S. M., Joiner M. C., Joiner M., van der Kogel A., The linear quadratic approach in clinical practice. Basic Clinical Radiobiology 2009 4th Hodder Arnold 120 134
51. Nahum A. E., Chapman J. D., The interaction between tissue radiobiological properties (architecture), dose distribution and optimal fraction size-profound implications for conformal and heavy-particle radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2003 55 446
52. Vogelius I. S., Westerly D. C., Cannon G. M., Bentzen S. M., Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncologica 2010 49 7 1052 1057 2-s2.0-77956573578 10.3109/0284186X.2010.498835
53. Uzan J., Nahum A. E., Radiobiologically guided optimisation of the prescription dose and fractionation scheme using BioSuite. British Journal of Radiology 2012 85 1279 1286
54. Fowler J. F., Tomé W. A., Fenwick J. D., Mehta M. P., A challenge to traditional radiation oncology. International Journal of Radiation Oncology, Biology, Physics 2004 60 4 1241 1256 2-s2.0-7444254382 10.1016/j.ijrobp.2004.07. 691 (Pubitemid 39440811)
55. Marks L. B., Bentzen S. M., Deasy J. O., Kong F. M., Bradley J. D., Vogelius I. S., El Naqa I., Hubbs J. L., Lebesque J. V., Timmerman R. D., Martel M. K., Jackson A., Radiation dose-volume effects in the lung. International Journal of Radiation Oncology, Biology, Physics 2010 76 3 S70 S76 2-s2.0-76449119210 10.1016/j.ijrobp.2009.06.091
56. Lax I., Blomgren H., Naslund I., Svanstrom R., Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncologica 1994 33 6 677 683 2-s2.0-0027945954 (Pubitemid 24345376)
57. Baumann P., Nyman J., Hoyer M., Wennberg B., Gagliardi G., Lax I., Drugge N., Ekberg L., Friesland S., Johansson K. A., Lund J. Å., Morhed E., Nilsson K., Levin N., Paludan M., Sederholm C., Traberg A., Wittgren L., Lewensohn R., Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. Journal of Clinical Oncology 2009 27 20 3290 3296 2-s2.0-70249108166 10.1200/JCO.2008.21.5681
58. Wennberg B. M., Baumann P., Gagliardi G., Nyman J., Drugge N., Hoyer M., Traberg A., Nilsson K., Morhed E., Ekberg L., Wittgren L., Lund J. Å., Levin N., Sederholm C., Lewensohn R., Lax I., NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncologica 2011 50 4 518 527 2-s2.0-79955578887 10.3109/0284186X.2010.543695
59. Schwarz M., Alber M., Lebesque J. V., Mijnheer B. J., Damen E. M. F., Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2005 62 2 561 570 2-s2.0-18944393954 10.1016/j.ijrobp.2005.02.011 (Pubitemid 40704476)
60. Iori M., Methods for physical and radiobiological optimisation in radiotherapy with intensity modulation. Physica Medica 2001 17 2 55 73 2-s2.0-0034840715
61. Brahme A., Individualizing cancer treatment: biological optimisation models in treatment and planning. International Journal of Radiation Oncology, Biology, Physics 2001 49 327 337 (Pubitemid 32120231)
62. Peñagarícano J. A., Papanikolaou N., Wu C., Yan Y., An assessment of Biologically-based Optimization (BORT) in the IMRT era. Medical Dosimetry 2005 30 1 12 19 2-s2.0-14644435158 10.1016/j.meddos.2004.10.003 (Pubitemid 40320888)
63. Hoffmann A. L., Den Hertog D., Siem A. Y. D., Kaanders J. H. A. M., Huizenga H., Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects. Physics in Medicine and Biology 2008 53 22 6345 6362 2-s2.0-56249086161 10.1088/0031-9155/53/22/006
64. Semenenko V. A., Reitz B., Day E., Qi X. S., Miften M., Li X. A., Evaluation of a commercial biologically based IMRT treatment planning system. Medical Physics 2008 35 12 5851 5860 2-s2.0-56749175428 10.1118/1.3013556
65. Uzan J., Nahum A. E., Mayles P., Syndikus I., Radiobiologically-based inverse optimisation of IMRT plans for prostate cancer. Radiotherapy & Oncology 2010 96 1, supplement S178
66. Witte M. G., Van Der Geer J., Schneider C., Lebesque J. V., Alber M., Van Herk M., IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. Medical Physics 2007 34 9 3544 3555 2-s2.0-34548359036 10.1118/1.2760027 (Pubitemid 47339751)
67. Engelsman M., Remeijer P., Van Herk M., Lebesque J. V., Mijnheer B. J., Damen E. M. F., Field size reduction enables Iso-NTCP escalation of tumor control probability for irradiation of lung tumors. International Journal of Radiation Oncology, Biology, Physics 2001 51 5 1290 1298 2-s2.0-0035577138 10.1016/S0360-3016(01)01729-1 (Pubitemid 33116323)
68. Baker M., Nielsen M., Hansen O., Jahn J. W., Korreman S., Brink C., Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion. International Journal of Radiation Oncology, Biology, Physics 2011 81 849 555 2-s2.0-79955722800 10.1016/j.ijrobp.2010.12.001
69. Popescu I. A., Chadrasekaran M., Uzan J., Furlong C., Scott A., Panettieri V., Nahum A. E., Radiobiological optimisation of 4D NSCL plans: small margins yield highest TCP for moving tumours. Radiotherapy & Oncology 2010 96 1, supplement S178
70. Kim Y., Tomé W. A., Dose-painting IMRT optimization using biological parameters. Acta Oncologica 2010 49 8 1374 1384 2-s2.0-77956596461 10.3109/02841861003767539
71. Bentzen S. M., Gregoire V., Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Seminars in Radiation Oncology 2011 21 2 101 110 2-s2.0-79952013846 10.1016/j.semradonc.2010.10.001
72. Sovik Å., Malinen E., Bruland O. S., Bentzen S. M., Olsen D. R., Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study. Physics in Medicine and Biology 2007 52 2 499 513 2-s2.0-33947713604 10.1088/0031-9155/52/2/013 (Pubitemid 46646466)
73. Iori M., Botti A., Paiusco M., Fioroni F., Cagni E., Grassi E., Foracchia M., Errico V. D., Nahum A. E., 18F-fluorocholine (F-CHO) PET-guided dose painting of prostate tumours using either TCP or EUD optimized to account for spatial clonogen redistribution. Radiotherapy & Oncology 2010 96 1, supplement S125
74. Otto K., Volumetric modulated arc therapy: IMRT in a single gantry arc. Medical Physics 2008 35 1 310 317 2-s2.0-37549049393 10.1118/1.2818738
75. Dearnaley D. P., Sydes M. R., Graham J. D., Aird E. G., Bottomley D., Cowan R. A., Huddart R. A., Jose C. C., Matthews J. H., Millar J., Moore A. R., Morgan R. C., Russell J. M., Scrase C. D., Stephens R. J., Syndikus I., Parmar M. K., Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncology 2007 8 6 475 487 2-s2.0-34249316816 10.1016/S1470-2045(07)70143-2 (Pubitemid 46805903)
76. Lambin P., Petit S. F., Aerts H. J. W. L., Van Elmpt W. J. C., Oberije C. J. G., Starmans M. H. W., Van Stiphout R. G. P. M., Van Dongen G. A. M. S., Muylle K., Flamen P., Dekker A. L. A. J., De Ruysscher D., The ESTRO Breur lecture 2009. from population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer. Radiotherapy and Oncology 2010 96 2 145 152 2-s2.0-77955709497 10.1016/j.radonc.2010.07.001
77. Rutkowska E., Mechanistic Simulation of Normal-Tissue damage during Radiotherapy [Ph.D. thesis] 2010 University of Liverpool
78. Tucker S. L., Li M., Xu T., Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. International Journal of Radiation Oncology, Biology, Physics. In press
79. Tucker S. L., Liu H. H., Liao Z., Wei X., Wang S., Jin H., Komaki R., Martel M. K., Mohan R., Analysis of radiation pneumonitis risk using a generalized Lyman model. International Journal of Radiation Oncology, Biology, Physics 2008 72 2 568 574 2-s2.0-51449099729 10.1016/j.ijrobp.2008.04.053
80. Valdagni R., Rancati T., Ghilotti M., Cozzarini C., Vavassori V., Fellin G., Fiorino C., Girelli G., Barra S., Zaffaroni N., Pierotti M. A., Gariboldi M., To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2009 74 5 1431 1440 2-s2.0-67651087472 10.1016/j.ijrobp.2008.10.021
81. Rancati T., Fiorino C., Fellin G., Vavassori V., Cagna E., Casanova Borca V., Girelli G., Menegotti L., Monti A. F., Tortoreto F., Delle Canne S., Valdagni R., Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer. Radiotherapy and Oncology 2011 100 124 130 2-s2.0-79959867777 10.1016/j.radonc.2011.06.032
82. West C. M. L., Elliott R. M., Burnet N. G., The genomics revolution and radiotherapy. Clinical Oncology 2007 19 6 470 480 2-s2.0-34347212511 10.1016/j.clon.2007.02.016 (Pubitemid 46995613)
83. Allen Li X., Alber M., Deasy J. O., The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Medical Physics 2012 39 1386 1409
84. Iori M., Cattaneo G. M., Cagni E., Fiorino C., Borasi G., Riccardo C., Iotti C., Fazio F., Nahum A. E., Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiotherapy and Oncology 2008 88 1 34 45 2-s2.0-46049115879 10.1016/j.radonc.2008.03.003
85. QUANTEC, International Journal of Radiation Oncology, Biology, Physics 2010 76 3, supplement
86. Fiorino C., Valdagni R., Rancati T., Sanguineti G., Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiotherapy and Oncology 2009 93 2 153 167 2-s2.0-70350474994 10.1016/j.radonc.2009.08.004
87. Gagliardi G., Constine L. S., Moiseenko V., Correa C., Pierce L. J., Allen A. M., Marks L. B., Radiation dose-volume effects in the heart. International Journal of Radiation Oncology, Biology, Physics 2010 76 3 S77 S85 2-s2.0-76449107176 10.1016/j.ijrobp.2009.04.093
88. Chapman J. D., Single-hit mechanism of tumour cell killing by radiation. International Journal of Radiation Biology 2003 79 2 71 81 2-s2.0-0037315233 (Pubitemid 36183066)
89. Wang J. Z., Huang Z., Lo S. S., Yuh W. T. C., Mayr N. A., A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Science Translational Medicine 2010 2 39 39ra48 2-s2.0-77955623159 10.1126/scitranslmed.3000864
90. Carlone M., Wilkins D., Raaphorst P., Guerrero M., Li X. A., The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour. Physics in Medicine and Biology 2005 50 10 L9 L15 2-s2.0-20044394233 10.1088/0031-9155/50/10/L01 (Pubitemid 40767808)
91. Kirkpatrick J. P., Brenner D. J., Orton C. G., The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Medical Physics 2009 36 8 3381 3384 2-s2.0-68149161660 10.1118/1.3157095
92. Tilly N., Radiobiological investigations of proton and light ion therapy [Ph.D. thesis] 2002 University of Stockholm
93. Dale R. G., Jones B., Cárabe-Fernández A., Why more needs to be known about RBE effects in modern radiotherapy. Applied Radiation and Isotopes 2009 67 3 387 392 2-s2.0-58549086325 10.1016/j.apradiso.2008.06.013
94. Nahum A., Gagliardi G., Kacperek A., How should we apply biological models to heavy charged-particle treatment plans? Radiotherapy & Oncology 2010 96 1, supplement S537
95. Wigg D. R., Applied Radiobiology and Bioeffect Planning 2001 Madison, Wis, USA Medical Physics Publishing
96. Dale R., Jones D., Radiobiological Modelling in Radiation Oncology 2007 London, UK British Institute of Radiology
97. Chapman J. D., Gillespie C. J., The power of radiation biophysics-let's use it. International Journal of Radiation Oncology, Biology, Physics 2012 84 309 311